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Abstract Lipids are essential for physiological pro-
cesses such as maintaining membrane integrity, pro-
viding a source of energy and acting as signalling
molecules to control processes including cell prolif-
eration, metabolism, inflammation and apoptosis.
Disruption of lipid homeostasis can promote patho-
logical changes that contribute towards biological
ageing and age-related diseases. Several age-related
diseases have been associated with altered lipid
metabolism and an elevation in highly damaging lipid
peroxidation products; the latter has been ascribed, at
least in part, to mitochondrial dysfunction and ele-
vated ROS formation. In addition, senescent cells,
which are known to contribute significantly to age-
related pathologies, are also associated with impaired
mitochondrial function and changes in lipid metabo-
lism. Therapeutic targeting of dysfunctional mito-
chondrial and pathological lipid metabolism is an
emerging strategy for alleviating their negative impact
during ageing and the progression to age-related
diseases. Such therapies could include the use of
drugs that prevent mitochondrial uncoupling, inhibit
inflammatory lipid synthesis, modulate lipid transport
or storage, reduce mitochondrial oxidative stress and
eliminate senescent cells from tissues. In this review,
we provide an overview of lipid structure and function,
with emphasis on mitochondrial lipids and their
potential for therapeutic targeting during ageing and
age-related disease.
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Introduction
Ageing can be considered as a progressive failure in
the maintenance of tissue homeostasis leading to
impaired function, health decline and the emergence
of age-related disease. Ageing likely involves the
dysregulation of several interconnected biological
processes including redox state, metabolism, cell
signalling, repair, replicative and adaptive capacity
(Calabrese et al. 2010). Tightly regulated metabolism,
the synthesis and degradation of macromolecules,
provides a fundamental quality control check and
energy resource. Recent evidence is emerging to
indicate that in addition to the longstanding link
between impaired lipid metabolism and atherosclero-
sis, lipid metabolism is also related to ageing.
However, while altered lipid metabolism has been
associated with and related to age-related diseases
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(Tindale et al. 2017; Dmitriev and Titov 2010; van
Diepen et al. 2013), it is often difficult to discern
whether such changes are a cause or a consequence of
ageing.
Age-associated impairment in mitochondrial func-
tion, including dysregulation of lipid metabolism and
increased reactive oxygen species (ROS) production,
may be one mechanism contributing to changes in
cellular energetics. The majority of mitochondrial
lipids are synthesised in the endoplasmic reticulum
(ER) and transported to the mitochondria, but some
lipids (cardiolipin, phosphatidylethanolamine) are
known to be synthesised within the inner membrane
of the mitochondria and are critical for maintaining the
unique architecture of the mitochondrial membranes,
the cristae (Schlame and Greenberg 2017). An
increase in ROS production may further exacerbate
mitochondrial dysfunction, partly via oxidative dam-
age to lipids (peroxidation), oxidation of respiratory
chain proteins affecting metabolism and protein
import, and in inducing DNA damage. The age-related
accumulation of mitochondria DNA (mtDNA) muta-
tions and respiratory chain dysfunction may lead to a
decline in mitochondrial function associated with
increased mitochondrial ROS production and a
decline in ROS-scavenging enzymes (Simoncini
et al. 2015). Mechanistic links between lipid metabo-
lism and inflammation have also been established,
where lipids can directly activate inflammatory path-
ways and vice versa (Pararasa et al. 2016; van Diepen
et al. 2013). In addition, mitochondrial dysfunction
has been linked to a shift in cellular metabolism
towards glycolysis, highlighting the tight relationship
between metabolism, energetics and ageing (Selfridge
et al. 2013).
If indeed mitochondrial dysfunction contributes to
significant lipid peroxidation, impaired lipid biosyn-
thesis and ageing itself, then therapeutic stabilisation
and restoration of mitochondrial function via targeted
treatment with antioxidants (Zhang et al. 2016; Cai
et al. 2015) may prove beneficial for alleviating age-
related decline.
Lipid metabolism and lipid composition changes
with ageing
Lipids are essential and multifunctional; they are
structural components of cell membranes, provide
energy reserves, mediate signal transduction and
indirectly, can regulate gene expression (Mecocci
et al. 1996; Elustondo et al. 2017). Interactions with
specific receptors or enzymes mediate the biological
effects of many lipid classes including ceramides,
eicosanoids, phosphoinositides, cholesterol and sph-
ingolipids. In turn, lipids play important roles in the
regulation of cell proliferation, apoptosis, inflamma-
tion, migration and adhesion (Ng et al. 2017; Helkin
et al. 2016; Mollinedo and Gajate 2015; Greig et al.
2012). Lipids, especially phospholipids (PL) have
important mitochondrial functions due to their promi-
nent roles in cell membrane formation, cell signalling
pathways and energy storage. Free fatty acids (FFAs)
are the major lipid constituents of membrane phos-
pholipids and during disease conditions phospholi-
pases are activated inducing PL hydrolysis and the
release of FFAs. Phosphatidylcholine (PC) is the most
abundant phospholipid present in the outer layer of the
cellular membrane and its concentration typically
increases with age (Hong et al. 2016). In Alzheimer’s
disease (AD), Hong et al. recorded a decrease in PCs
and increase in lysophatidylcholine (LPC) formed by
hyperactivated phospholipase 2 (Hong et al. 2016). PL
enable important neuronal functions including neuro-
transmission, stabilisation of ion channels and the
localisation of b-amyloid plaques to PL cores (Hong
et al. 2016).
Many age-related diseases including cardiovascu-
lar diseases, diabetes, kidney disease, rheumatoid
arthritis and neurodegenerative diseases are associated
with altered lipid metabolism and consequently
changes in lipid profiles (Greig et al. 2012; AbouAssi
et al. 2017; Zhang and Forman 2016; Helkin et al.
2016; Pararasa et al. 2015).Whiley et al. identified that
some long chain PCs (16:0/20:5; 16:0/22:6 and 18:0/
22:6) were at significantly lower concentrations in AD
patients, particularly 16:0/20:5 (Whiley et al. 2014);
noticeable reduction of sulfatides has also been found
in AD (Hong et al. 2016). Gaudin et al. also found that
PC with very long chain fatty acids (32:0 and 34:0)
increased in AD (Gaudin et al. 2012). Conversely,
sphingomyelin is reported to be at lower concentra-
tions in AD patients compared to controls (Hong et al.
2016; Whiley et al. 2014).
Dysregulation in lipid desaturation may disrupt
normal cell processes, for example, the decline in
omega 3 fatty acids that is observed in ageing is
considered proinflammatory. This is likely to arise
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from lower expression of the delta 6 desaturase
enzyme. An inter-relationship between mitochondrial
gene expression and lipid profiles was demonstrated in
an elegant GWAS study; ten genetic variants-mtSNPs
were associated with HDL cholesterol and triglyceride
levels, highlighting the importance of the mitochon-
drial genome to the regulation of lipid levels (Flaquer
Rospleszcz et al. 2015) in cardiovascular disease.
One of the most visible signs of ageing is an
alteration in visceral and subcutaneous fat deposition;
there is less subcutaneous fat deposited under the skin
which not only impairs thermostasis but also reduces
the potential for glucose and fatty acid disposal and
insulin resistance (Torres-Villalobos et al. 2016),
probably due to changes in hormone secretion
(Pararasa et al. 2015). Fat accumulates at ectopic sites
with age, such as the bone marrow, muscle and the
liver. This may be cytotoxic to emergent immune
cells, satellite cells and increase non-alcoholic fatty
liver disease (Heilbronn et al. 2004) and can exacer-
bate insulin resistance (Gao et al. 2009). The most
important fatty acid in lipotoxicity is palmitate that is
converted to ceramides intracellularly (Gao et al.
2012). Palmitate, probably via ceramide, is an uncou-
pler of mitochondria, promoting release of ROS in a
range of cell types (Phillips et al. 2002).
Deposition of visceral and subcutaneous fat is
dependent on the size of the adipocyte pool and
efficiency of converting fatty acids into triglyceride.
The peroxisome proliferator activated receptor c
(PPARc) transcription factor family regulates the
expression of genes that catalyse the conversion of
fatty acids into triglyceride for storage in a tissue
specific manner (Nakamura et al. 2014). Metabolic
switching between energy sources can also be con-
trolled by PPARc in immune cells (Griffiths et al.
2017) highlighting a tight relationship between
metabolism and immune function (Torrao et al.
2014). Intriguingly, PPARc expression by Treg cells
is necessary to restore insulin sensitivity in obese mice
(Cipolletta et al. 2012). In common with adipocytes,
PPARc is phosphorylated at Ser273 by Cdk5 in
visceral adipose tissue Treg cells (Cipolletta et al.
2015).
The importance of fatty acid storage for longevity
was elegantly demonstrated in a PPARc deficient
mouse that showed reduced lifespan; moreover, an in
silico study suggested that the PPARc signalling
pathway was part of a longevity network (Argmann
et al. 2009). With age, there is a decline in pre-
adipocyte proliferation and differentiation (Sepe et al.
2011). This is likely to contribute to the increased
systemic load of free fatty acids that we and others
have described during healthy ageing (Pararasa et al.
2016).
In our previous study of fatty acids in plasma, we
showed that the longer chain fatty acids (C14–C22)
were increased in the healthy over 65 years of age
group. This effect may be related to the observed
increase in methylation of the Elongation of Very
Long Chain Fatty Acids 2 (ELOVL2) promoter that
has been reported in monocytes and T cells with age
(Reynolds et al. 2014). Decreased expression of
ELOVL2, which catalyses the extension of C20 and
C22 poly unsaturated fatty acid (PUFA) (arachidonic
acid and eicosopentanoic acid) to form very long chain
unsaturated fatty acids, offers an explanation for the
accumulation of ELOVL2 substrates that we
observed. Both n-6 and n-3 PUFAs are a component
of membrane phospholipid thus changes in their
frequency will influence both the structure and func-
tion of the membrane (Ma et al. 2004). Finally,
ELOVL2 also plays an important role in triglyceride
storage and lower expression promotes an increase in
fatty acid release by adipocytes (Kobayashi et al.
2007).
Consistent with other changes seen in fatty acid
metabolism, plasma cholesterol levels tend to increase
with age. However, this effect is not uniform across
lipid classes; plasma LDL increases whereas HDL
concentrations tend to be lower (Davidson et al. 2002;
Walter 2009). The net effect is that cholesterol
transport into cells is increased but reverse cholesterol
transport out of cells to HDL decreases. Cholesterol
together with ceramides can confer changes in mem-
brane fluidity in the phospholipid bilayer and affect the
formation of lipid raft microdomains; accumulating
data suggest that the function of lipid microdomains is
altered with ageing and can impair immune signalling
(Fulop et al. 2012).
Several studies have highlighted differences in the
lipid profile of male and females relating to age.
Higher total cholesterol (TC), low-density lipoprotein
cholesterol (LDL), and non-high-density lipoprotein
cholesterol (N-HDL) in the non-elderly compared
with the elderly for both males and females (Wei et al.
2014). Compared with females, males have higher
HDL while females have high LDL with no difference
Biogerontology (2017) 18:859–879 861
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in HDL among various age groups for females but
there was significance for males (Goh et al. 2007; Wei
et al. 2014). Triacylglycerol (TG) was reported to be
significantly different in males of different age groups
but no difference was observed in TG for females. TG
levels were higher in 40–49, 50–59, and 60–69 year
age groups in males than those in 70–79, 80–89,
and C90 year age groups (Wei et al. 2014).
Goh et al. (2007) evaluated the impact of age and
gender on lipid and lipoprotein profiles in a cohort of
healthy Chinese-Singaporean and found no significant
difference in the lipid and lipoprotein levels in men of
different age groups but observed significantly higher
level of some lipids in older women ([50 years old)
than in younger women (30–46 years old). They also
reported TG to be significantly correlated with lipids
and lipoproteins differently in men and women (Goh
et al. 2007).
Reynolds et al. (2010) evaluated the relationship
between serum lipids and cognitive decline in men and
women from the ages of 50–96 years. Among their
findings, TG predicted memory ability in women
across all ages with low TG predicting general
cognitive ability while in men apolipoprotein B and
TC levels correlated with better cognitive function.
The gender effect seen in the lipid profile has been
associated with the hormone androgen (Reynolds et al.
2010).
Metabolism is required to provide ATP for cell
survival. The most efficient mode of ATP production
is via oxidative phosphorylation in the mitochondrion
and is supplied from the degradation of carbohydrates,
proteins and lipids. Normally, oxidative phosphoryla-
tion is a tightly coupled process of two electron
transfer in the presence of oxygen, yielding ATP and
water. However, in conditions of nutrient excess or
when components of the electron transport chain are
modified, single electrons may leak (Jackson et al.
2002). The first product of single electron leakage is
the reactive oxygen species (ROS), superoxide anion.
Superoxide itself has relatively low reactivity and
probably does not contribute to any major oxidative
damage. However, superoxide spontaneously dismu-
tates to hydrogen peroxide which is membrane
permeable and is a powerful oxidant generating
hydroxyl radicals via the Fenton reaction in the
presence of catalytic iron. During oxidative stress,
the imbalance in oxidants and antioxidant levels
results in oxidative damage to macromolecules
(Simoncini et al. 2015; Gandhi and Abramov 2012).
The uncontrolled oxidation of lipids mediated by
reactive oxygen species (ROS) is known as peroxida-
tion. Peroxidation causes fundamental changes in
molecular properties. For example phospholipids are
essential for membrane architecture, but peroxidation
causes changes in fluidity which can influence recep-
tor clustering and yield bioactive and inflammatory
oxidised phospholipids. Peroxidation is considered in
the next section.
Hydrogen peroxide can mediate oxidation of thio-
late anions found in cysteine residues that have a
pKa *5 and this is considered to be an important
reaction for inactivation of tyrosine phosphatases and
for propagating inflammatory signalling (Ratnayake
et al. 2013). The intermediate sulphenic acid can be
reduced by glutathione (GSH), catalysed by glu-
tathione reductase, although this reaction is limited
during ageing as GSH concentrations tend to be lower.
Superoxide may also combine with nitric oxide to
form peroxynitrite, another lipophilic species that can
cross biological membranes and exert oxidising and
nitrating reactions. Oxidation of cysteine residues in
the iron-sulphur clusters of the mitochondria can
further exacerbate ROS leakage (Sheeran and Pepe
2016).
During ageing, the integrity of the mitochondrial
respiratory chain is compromised. ROS-induced mito-
chondria DNA mutation/damage, lipid and protein
oxidation, affect physiological functions (Cui et al.
2012). In this state, cellular antioxidant defences are
insufficient to keep the ROS levels below a toxic level
(Simoncini et al. 2015). Age related accumulation of
ROS has been suggested to play a part in the damage to
major cell components in age-related diseases (Si-
moncini et al. 2015).
ROS induced lipid peroxidation
Lipid peroxidation is a biologically important process
that results in intermediate unstable oxidised lipid
species and stable end products, which act as bioactive
lipid mediators. Being more polar than their parent
lipids, lipid peroxides (LPOs) can perturb membrane
bilayers, affect membrane structure and interfere with
intracellular functions. Phospholipid peroxidation
changes membrane biophysical properties, decreasing
fluidity, inactivating membrane-bound proteins and
862 Biogerontology (2017) 18:859–879
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ultimately leads to destruction of the membrane
(Wong-ekkabut et al. 2007).
Products of peroxidation, lipid-oxides and –perox-
ides, are reported to be involved in many cellular
processes including cellular metabolism, signalling,
and cell survival (Aufschnaiter et al. 2017). Lipid
molecules, especially PUFA and cholesterol, undergo
oxidation at varied rates initiated by ROS [e.g.
hydroxyl radicals (OH), superoxide (O2–), peroxyl
radical (ROO–), nitric oxide (NO), peroxynitrite
(ONOO–) or nitrogen dioxide (NO2)], and in PUFA
this initiates a self-propagating chain reaction (Halli-
well 2001). The propagation stage of lipid peroxida-
tion involves electron transfer and oxidation of other
PUFA in close proximity. Propagation and termina-
tion have been reviewed extensively elsewhere (Yin
et al. 2011; Girotti 1998). Non-enzymatically gener-
ated lipid peroxides often have a very short half-life
and therefore pose technical challenges for precise
measurement and biological study. Mass spectrometry
is seen as the method of choice for absolute determi-
nation of lipid peroxidation.
In our recent work, we explained some challenges
with oxidative lipidomic techniques and reported the
detection of lipid oxidation by analysing the novel
oxidised phospholipid biomarker 1-palmitoyl-2-(5’-
oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC),
a truncated oxidation product of 1-palmitoyl-2-arachi-
donoyl-sn-phosphatidylcholine (PAPC) using electro-
spray ionization tandem mass spectrometry (MS) with
multiple reaction monitoring (MRM) (Ademowo et al.
2017). Several authors have used antioxidant activities
and oxidative stress derived biomarkers to detect and
analyse lipid peroxidation (Cai et al. 2017; Umeno
et al. 2017; Ademowo et al. 2017). Gaschler and
Stockwell reviewed in details several other methods
for the detection and analysis of lipid peroxidation in
biological samples [see (Gaschler and Stockwell
2017)].
Oxidised phospholipids (oxPLs) are generated from
(poly)unsaturated diacyl- and alk(en)ylacyl glyc-
erophospholipids. OxPLs exert a wide variety of
biological effects and play a role in the development of
several chronic diseases (Philippova et al. 2014). In
pathological conditions associated with activation of
oxidative stress, unsaturated phosphatidylcholines, the
most abundant phospholipids undergo oxidation lead-
ing to generation of fragmented phospholipids such as
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
(lysoPC), or 1-palmitoyl-2-arachidonoyl-sn-glycero-
3-phosphocholine (PAPC) full length oxygenation
products (oxPAPC) (Heffern et al. 2013). Other
oxidised derivative of PAPC are 1–palmitoyl-2–(5–
oxovaleroyl)- sn -glycero-3–phosphocholine (POVPC),
5–hydroxy-8–oxo-6–octenoyl-phosphocholine (HOOA-
PC), 1–palmitoyl-2–(5,6–epoxyisoprostane E2)- sn -
glycero-3–phosphocholine (PEIPC), and 1–palmitoyl-
2–glutaroyl- sn -glycero-3–phosphocholine (PGPC)
(Philippova et al. 2014). Eicosanoids including prosta-
glandins, thromboxanes and leukotrienes are also prod-
ucts of arachidonic acid oxidation and they play major
regulatory roles in immune and inflammatory functions
(Rubio-Perez and Morillas-Ruiz 2012).
Although oxPLs are recognized to be involved in
disease pathogenesis, others reported that the converse
is true under certain biological conditions (Mauerhofer
et al. 2016). Mauerhofer et al. have demonstrated that
OxPLs can also induce protective effects such as
inhibition of inflammatory signaling pathways through
Nrf2-dependent and -independent mechanisms, upreg-
ulation of antioxidant genes, antagonism of Toll-like
receptors. The immuno-modulating and immuno-sup-
pressive action of OxPLs may influence adaptive
immunity and autoimmune disease through activation
of PPARs which are known for their anti-inflammatory
action. OxPLs may also inhibit inflammation induced
via TLR4 (Bochkov et al. 2010). Hence, phospholipid
oxidation may provide a negative feedback to prevent
damage to host tissues from uncontrolled inflammation
and oxidative stress (Mauerhofer et al. 2016).
Whilst cholesterol-derived hydroperoxides are
more stable and have been studied both in model
systems and cells (van Lier et al. 2015), the analysis of
the predominant lipid peroxide species in fluids and
tissue in health and how they change in disease
requires methodological precision and sensitivity
(Reis 2017). Due to the instability of many other
intermediate products, PUFA-derived stable aldehydes
such as 4-hydroxy-2-nonenal (HNE), malondialde-
hyde (MDA) and acrolein are the most extensive
species that are studied (Esterbauer et al. 1991; Ayala
et al. 2014; Zhang and Forman 2016). HNE and MDA
show high chemical reactivity and interact with
proteins, resulting in the formation of covalent adducts
that can be measured by ELISA and often modulating
protein activity (Liu et al. 2014b) including in proteins
in the membrane (Pizzimenti et al. 2013). The
majority of studies have focussed on the
Biogerontology (2017) 18:859–879 863
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aforementioned three stable aldehydes, however,
advances in analytical capability using advanced MS
methods are revealing many other interesting and less
well-studied carbonyl compounds (Sousa et al. 2017).
Products of lipid peroxidation are often reactive
themselves and are classified as either hydroxyl acids
or reactive aldehydes (Gaschler and Stockwell 2017).
Due to the ability of lipid peroxidation products such
as aldehydes to covalently modify proteins, Shibati
et al. used mass spectrometry methods to detect
product ions generated from positively ionised adducts
(Shibata et al. 2017). In future, in depth studies using
state of the art MS methods will help us to understand
more about targets and potentially mechanisms of
lipid peroxidation involving protein adducts in ageing.
Zheng et al. (2005) measured HNE-adduct accu-
mulation in ageing in fruit flies using an ELISA
method and found that HNE adduct concentrations are
significantly increased in the second half of the adult
life by two fold (Zheng et al. 2005). Another study
using ageing Wistar rats at 7, 15, 22 and 30 weeks
found significantly increased levels of HNE-protein
adducts with ageing (Asselin et al. 2006).
Isoprostanes (IsoPs) are prostaglandin F2-like
compounds and neuroprostanes (NPs) that are formed
by the non-enzymatic, free radical-mediated oxidation
of arachidonate and docosahexaenoate, respectively.
IsoPs have been measured in biological fluids such as
urine, plasma, bile, cerebrospinal fluids, and in many
cell and tissue types (Dias et al. 2015; Cracowski
2004; Ademowo et al. 2017). Choksi et al. (2007)
showed lower serum and liver IsoP levels at all ages in
Dwarf mice that show inherently low levels of ROS.
The authors suggested that lower levels of endogenous
ROS production may be a factor in their resistance to
oxidative stress and longevity (Choksi et al. 2007).
Garcı´a-Flores et al. (2017) analysed F2-dihomo-
isoprostanes, F3-neuroprostanes, and F4-neuro-
prostanes- in urine samples from 158 healthy volun-
teers ranging from 4 to 88 years old. They found a
significant, positive correlation between age and total
F2-dihomo-IsoP concentration (Garcı´a-Flores et al.
2017). To further investigate any relationship between
lipid peroxidation and ageing, a cohort study was
undertaken in a geriatric population; circulating MDA
was related to frailty and not to age or sex (Ingle´s et al.
2014).
An increase of LPOs is commonly found in many
age-related diseases. Skewing of the redox balance
towards oxidation is observed in biological ageing and
in many inflammatory diseases that increase with age.
Table 1 provides examples of organs and diseases that
are associated with increased LPOs.
To minimise lipid peroxide and reactive aldehyde
accumulation to subtoxic levels, cells have a vast
network of antioxidant and detoxification systems.
Removal of aldehydes is achieved by glutathione
(GSH) that reacts with aldehydes to formGSH adducts
either spontaneously or catalysed by glutathione
S-transferases (GSTs), by aldo–keto reductases
(AKRs) to alcohols or oxidation to acids by aldehyde
dehydrogenases. The redoxins (thioredoxin, peroxire-
doxin, glutaredoxin) and dismutase enzymes also play
a role in the detoxification process and have been
reviewed elsewhere (Zimniak 2008; Krag 2011).
Increased LPO products observed in biological ageing
are likely to be a result of increased production and
decreased removal caused by age-associated dysfunc-
tion of detoxification.
Mitochondrial lipids in biological ageing and age-
related diseases
Mitochondria are cytoplasmic organelles with a char-
acteristic double-membrane structure and have been
described as the ‘‘powerhouses’’ of the cell, generating
the energy needed to function and survive (Reddy and
Beal 2005; Yin et al. 2015; Simoncini et al. 2015).
Mitochondria perform electron transport producing
adenosine triphosphate (ATP) (Swerdlow and Khan
2004) and regulate the initiation of apoptosis by
releasing proteins that activate the caspase family
proteases. Disruption of the electron transport chain
(ETC) affects the reduction–oxidation (redox) poten-
tial of the cell. This impacts on signalling pathways
through modulation of SIRT (Griffiths et al. 2017) and
by oxidising reduced NADH to NAD? needed in
glycolysis (Selfridge et al. 2013). Mitochondria are the
greatest cellular source of ROS as the electron
transport consumes about 85% of the oxygen that the
cell uses (Reddy and Beal 2005). An impaired ETC
reduces ATP energy but increases ROS production.
During biological ageing, aberrations in the control of
cell death, impaired metabolism and perturbed redox
homeostasis have been attributed to mitochondrial
dysfunction (Yin et al. 2015) and in the pathogenesis
of inflammation (Wan et al. 2014) and age related
864 Biogerontology (2017) 18:859–879
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diseases including neurodegenerative diseases (Di
Domenico et al. 2016), diabetes (Vadvalkar et al.
2017) and cardiovascular diseases (Li et al. 2017).
As a source of ROS production, mitochondria are
particularly susceptible to locally mediated oxidative
damage to lipids, DNA and proteins; the latter are
normally limited by effective oxidative DNA damage
repair enzymes and the Lon protease respectively.
Secondary, oxidative DNA damage from lipid perox-
idation products may contribute to the increasing
numbers of mitochondrial mutations seen in diseases
and inactive respiratory complexes, so promoting
further ROS leakage in a vicious cycle of oxidative
damage (Yao and Brinton 2011; Tanaka et al. 1996).
The structural and functional arrangement of mito-
chondrial protein complexes within the membrane
changes with age. These structural changes affect the
ion mobility disrupting the carrier proteins that shuttle
ions, ATP, ADP and small metabolites between the
cytoplasm and the matrix; these proteins include the
33 kDa ATP/ADP carrier, the soluble electron carrier
protein, cytochrome c and enzymes such as the ATP
synthase, succinate dehydrogenase and other oxido-
reductases (Pebay-Peyroula et al. 2003; Ku¨hlbrandt
2015). However, whether or not the morphological
changes seen in mitochondria during ageing are direct
or indirect consequences of oxidative damage to
proteins and lipids is not known. The biogenesis of
mitochondrial proteins during ageing is not well
explored and due to the dynamic and fragile nature
of mitochondria protein complexes, they are not easily
analysed by established methods (Ku¨hlbrandt 2015).
Hence the effects of age-related changes to mitochon-
drial lipid and protein complexes are emerging areas
of research.
Cardiolipin (CL), a form of glycerophospholipid
found in the inner membrane of the mitochondrial
lipid bilayer, has an important structural role acting as
an anchor for respiratory super-complexes and for
mitochondrial DNA during replication. CL is essential
for mitochondrial health (Shen et al. 2015) and CL
oxidation has been identified as a primary event in the
release of cytochrome c and to increase permeability
of the mitochondrial membrane to apoptosis factors
such as BAX and BAD. The release of cytochrome c
was suppressed when the production of ox-CL in
mitochondria was inhibited by the overexpression of
mitochondrial phospholipid hydroperoxide glu-
tathione peroxidase (Nomura et al. 2000).
As an anionic phospholipid, cardiolipin is very
susceptible to oxidation; this affects respiration, the
assembly and stability of the mitochondrial protein
import machinery, may cause abnormal mitochondrial
morphology and even promote cell death (Horvath and
Daum 2013). Recently, a pentapaptide-SS31 has been
discovered to bind and protect cardiolipin from
oxidation. It has been shown to improve mitochondrial
function in ageing muscle, maintain the structure of
cristae and protect neurons from hypoxia reperfusion
injury (Birk et al. 2014).
Table 1 Increased lipid peroxidation products in age related diseases
Organ Diseases Example references
Brain Trauma, stroke, neurodegenerative diseases Naudı´ et al. (2017), Zhang and Forman (2016) and
Hall et al. (2016)
Eye Cataractogenesis, retinal damage Liu et al. (2014a) and Mark and Anne (2009)
Blood and blood vessels Atherosclerosis Dias et al. (2015) and Geng et al. (2015)
Skin Dermatitis Zheng et al. (2014)
Heart Cardiovascular disease Pytel et al. (2016) and Tejovathi et al. (2013)
Teeth and gum Periodontitis Baltacıog˘lu et al. (2014) and Akalin et al. (2007)
Liver Chronic liver disease Morita et al. (2012) and Vuppalanchi et al. (2011)
Pancreas Diabetes, chronic pancreatitis Wensaas et al. (2009) and Santini et al. (2003)
Lung Asthma, hypoxia Wood et al. (2003) and Diamond et al. (2016)
Kidney Chronic kidney disease De Vecchi et al. (2009) and Vaziri and Norris (2011)
Bone and joints Arthritis Sarban et al. (2005)
Multiple organs Cancer Herrera et al. (2014)
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Mitochondrial lipids in neurodegeneration
Although the central nervous system (CNS) function is
dependent on efficient mitochondrial activity due to its
energy requirement, it is still unclear whether or not
mitochondrial impairment and oxidative stress are
actually involved at the onset or progression of
neurodegeneration and some other diseases (Si-
moncini et al. 2015). Mitochondria are rapidly trans-
ported to areas of high energy demand such as the
neuronal projections (Selfridge et al. 2013). The
mitochondrial transport is important for the develop-
ment, function and stability of synapses and dendritic
spines (Selfridge et al. 2013).
Mitochondrial dysfunction has been reported to be
one of the earliest and prominent features in neurode-
generative disorders as ROS are produced locally and
target the mitochondria causing the oxidation (Si-
moncini et al. 2015). Emerging research has strongly
implicated mitochondrial dysfunction as causal in the
brain energy deficit and failure to adapt to stressors
observed in neurodegenerative diseases such as AD;
mitochondrial abnormalities are part of AD phenotype
(Selfridge et al. 2013). The decline in glucose
metabolism and mitochondrial function with
increased oxidative stress often appears decades
before onset of clinical/pathological symptoms of
the disease (Yao and Brinton 2011), hence, ROS have
been suggested to be the cause rather than the
consequence of neurodegeneration (Moreira et al.
2009). During AD progression, lower glucose utiliza-
tion and exhaustion of the ketone reservoir increases
mitochondrial dysfunction and the fatty acid oxidation
pathway which results in white matter degeneration
and eventually neuronal death (Yao and Brinton
2011).
Fundamental changes in the composition and
distribution of lipids within the brain are believed to
contribute to the cognitive decline associated with
ageing. The mechanisms by which these changes in
lipid composition affect cellular function and ulti-
mately cognition are not well understood (Kennedy
et al. 2016; Hong et al. 2016; Whiley et al. 2014).
However, Kennedy et al. identified the mitochondria
as an important downstream target of PC(O-16:0/2:0),
a neurotoxic lipid species found to be increased in AD
and that PC(O-16:0/2:0) promotes a global increase in
ceramide accumulation in human neurons, associated
with mitochondrial-derived ROS and toxicity. These
data suggest that PC(O-16:0/2:0)-dependent mito-
chondrial dysfunction may be an underlying factor
for increased ROS production associated with AD
(Kennedy et al. 2016). The mitochondrion-located
antioxidant enzyme copper/zinc superoxide dismutase
is significantly decreased in the frontal and temporal
cortex of AD brain, rendering the AD mitochondrion
at increased risk for oxidation and offering a possible
explanation as to why brain cells (astrocytes, neurones
and glial cells) are more susceptible to mitochondrial
dysfunction in AD (Reddy and Beal 2005; Moreira
et al. 2009).
Mitochondrial lipids in diabetes
Type 2 diabetes mellitus (T2DM) is the most common
human endocrine disease and is characterized by
peripheral insulin resistance and pancreatic islet b-cell
failure resulting fat deposition in adipose tissue.
Pancreatic islet b-cell mitochondria promote lipid
oxidation, increase lipogenesis and activate several
stress-response pathways in diabetes (Chattopadhyay
et al. 2015).
Kahle et al. (2015) took a targeted metabolomics
approach to identify high fat (HF) diet-induced
modifications in membrane lipid and mitochondrial-
membrane protein signatures in mouse liver cells.
After 7, 14, and 21 days exposure to an HF diet rich in
polyunsaturated fatty acids, hepatosteatosis was
induced and major lipid constituent signatures in liver
were modified e.g. increased total unsaturated, long-
chain fatty acid-containing acyl-carnitine or mem-
brane-associated diacylglycerol moieties and
decreased total short-chain acyl-carnitines, glyc-
erophosphocholines, lysophosphatidylcholines, or
sphingolipids. The HF diet progressively decreased
the abundance of protein-components of all mito-
chondrial respiratory chain complexes, inner and outer
mitochondrial membrane substrate transporters
impacting on energy metabolism in liver cells (Kahle
et al. 2015).
Using shotgun lipidomics data with multidimen-
sional mass spectrometry, Han et al. (2005) identified
a significant decrease in cardiolipin levels and alter-
ations of cardiolipin acyl chain remodelling in diabetic
murine myocardium, linking altered substrate utiliza-
tion and metabolic flux with the diabetic heart (Han
et al. 2005). Transgenic expression of cardiolipin
synthase in a streptozotocin-induced diabetic mouse
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model, accelerated cardiolipin remodelling, improved
mitochondrial function and attenuated mitochondrial
dysfunction during diabetes (Kiebish et al. 2012). This
study highlights an avenue to target mitochondrial
bioenergetics via cardiolipin synthase.
Mitochondrial lipids in cardiovascular diseases
Mitochondria play an important role in cardiomy-
ocytes by sustaining ATP production to satisfy the
high demand for energy and the normal function of the
heart. Even subtle alterations in mitochondrial func-
tion or membrane potential e.g. through peroxidation,
can cause a significant change in cardiomyocyte
energy production and deleterious consequences in
cardiovascular health (Pytel et al. 2016). Increased
mitochondrial ROS and reactive nitrogen species
production during the early stages of hypoxia are
associated with cardiomyocyte toxicity (Kolamunne
et al. 2013). Lower levels of CL were observed in the
rat ischemia–reperfusion model and a decrease in
mitochondrial complex III activity was also observed
(Paradies et al. 2004). A proteomic study by (Pavo´n
et al. 2011) revealed that proteins of the electron
transport chain constituted the greatest percentage of
altered lipid-adducted proteins in rat cardiac mito-
chondria treated with a spectrum of lipid peroxidation
products including HNE and 4-hydroxyhexanal
(HHE). While a high level (C20 lM) of HNE was
cardio-toxic, levels around 5 lM of HNE induced
endogenous anti-oxidant systems through Nrf2 acti-
vation (Dasuri et al. 2009).
As mitochondria have been referred to as the most
important determinant of life span (Sun et al. 2014),
there is a need to understand mitochondrial bioener-
getics in prodromal and extant age-related diseases; to
explore signature markers of disease that identify
onset and progression; and to investigate different
interventions that could prevent or delay the progres-
sion of such diseases.
Mitochondrial ROS production during cellular
senescence
As we have discussed previously, impaired mitochon-
drial function and elevated ROS production associate
with altered lipid metabolism and increased lipid
oxidation that is observed in several age-related
diseases. Senescent cells are one potential source of
mitochondrial dysfunction during ageing.
Cellular senescence can be considered as a pro-
grammed change in cell state, associated with irre-
versible proliferative arrest and often accompanied by
conversion to a pro-inflammatory, immunogenic phe-
notype (Burton and Krizhanovsky 2014). In contrast,
cell ageing occurs as a result of accumulating
stochastic damage over time, leading to gradual
impairment in cell function. Senescent cells are not
aged/old cells. Although, cell senescence can be
induced at random, independent of age, the accompa-
nying changes associated with cell senescence are
highly regulated.
Cells become senescent in response to various
stress-inducing stimuli such as ROS, telomere dys-
function and oncogene activation, which consequently
initiates a persistent DNA damage response (DDR)
(Di Micco et al. 2006; Rodier et al. 2009; Rossiello
et al. 2014). In recent years, cell senescence has
emerged as a major mechanism promoting biological
ageing and age-related diseases (Childs et al. 2015;
Mun˜oz-Espı´n and Serrano 2014; van Deursen 2014)
and as such, a discussion on the potential connection
between cellular senescence, mitochondrial dysfunc-
tion and lipid metabolism is warranted.
The senescent state has been shown to be associated
with a shift from mitochondrial respiration towards
glycolysis (Aird and Zhang 2014; James et al. 2015)
and whilst mitochondrial dysfunction may contribute
to this metabolic shift, induction of glycolysis itself
could possibly contribute to mitochondrial dysfunc-
tion (Senyilmaz and Teleman 2015). An elevation in
ROS production in response to impaired mitochon-
drial function could theoretically activate a DDR,
triggering cellular senescence and activating their pro-
ageing responses.
To determine whether mitochondrial dysfunction
can promote cellular senescence, Wiley et al. depleted
mtDNA in IMR90 fibroblasts, treated cells with
electron transport chain inhibitors (rotenone or anti-
mycin A) or depleted cells of the mitochondrial
chaperone HSPA9 (Wiley et al. 2016). All treatments
were shown to induce cell senescence as evident by
reduced BrdU incorporation and increased senes-
cence-associated beta galactosidase staining. To eval-
uate the potential role of mitochondria in orchestrating
the pro-ageing features of the senescent phenotype,
Correia-Melo et al. demonstrated that senescent cells
Biogerontology (2017) 18:859–879 867
123
lacking mitochondria reduced many aspects of the
senescent phenotype including the pro-inflammatory
secretome, whilst maintaining ATP production via
enhanced glycolysis (Correia-Melo et al. 2016).
Findings by Passos et al. suggest that ROS are initially
important for the maintenance of cell senescence
through sustaining a persistent DNA damage response
(DDR) (Passos et al. 2010). This may suggest that
ROS production is initially beneficial during the
transient appearance of cell senescence, but if senes-
cent cells persist in tissues, likely owing to impaired
clearance by the immune system (Burton and Faragher
2015), persistent senescent cells later become harmful.
In principle, these data suggest that disruption to
mitochondrial function could promote cellular senes-
cence, in addition to regulating the pro-ageing features
of senescent cells. However, these studies do not
provide evidence that such mechanistic processes
occur during natural ageing in the absence of exper-
imental intervention. Nevertheless, because senescent
cells are associated with many age-related diseases,
whether mitochondrial dysfunction is a cause or a
consequence of cell senescence may not be a primary
point of issue. What is of concern is the long-term
biological impact of altered processes such as lipid
metabolism and lipid peroxidation when senescent
cells persist.
Lipids and lipid peroxidation during cellular
senescence
Mitochondrial dysfunction, increased lipid peroxida-
tion and altered catabolism will affect the cellular
lipidome during cell senescence. Alterations in lipid
metabolism and the generation of oxidised lipids may
be beneficial for the senescent program during the
early stages of senescence induction, possibly through
modulating inflammatory and immune responses
(Lawrence et al. 2002; van Diepen et al. 2013; Yaqoob
2003). However, if senescent cells persist in tissues,
changes in lipid composition can result in cell
dysfunction, altered rates of fatty acid oxidation that
can induce inflammation and increased lipid peroxi-
dation that can promote damage to neighbouring cells
(Fig. 1). These factors may contribute to ageing and
age-related diseases. Research focused on altered lipid
metabolism during cellular senescence, particularly
regarding mitochondrial lipids, is in its infancy.
However, in recent years, several studies have made
progress in evaluating the senescent lipidome of
fibroblasts.
One group investigated the alterations in a number
of metabolites associated with the extracellular
metabolome of fibroblasts induced to senesce via
proliferative exhaustion or via c-irradiation (James
et al. 2015). They reported that a number of fatty acids
and their precursors such as eicosapentaenoate,
malonate, 7-alpha-hydroxy-3-oxo-4-cholestenoate
and 1-stearoylglycerophosphoinositol were elevated
during fibroblast senescence when compared with
proliferating and quiescent cells, whereas linoleate,
dihomo-linoleate, 10-heptadecenoate were depleted.
Also amongst the secretory lipidome from senescent
fibroblasts was an accumulation of monohydroxy fatty
acids (2-hydroxypalmitate, 2-hydroxystearate, 3-hy-
droxydecanoate, 3-hydroxyoctanoate) and a phospho-
lipid catabolite (glycerophosphorylcholine). It was
suggested that whilst some of these changes may be
due to oxidative stress, other observed increases may
be a response to increased biomass commonly
observed amongst senescent cells.
Maeda et al. (2009) investigated the regulation of
fatty acid synthesis and D9-desaturation during cell
senescence in human fibroblasts (Maeda et al. 2009).
They found that the levels of fatty acid synthase and
stearoyl-CoA desaturase-1 were decreased in senes-
cent fibroblasts compared to proliferating fibroblasts,
consequently leading to a decrease in monounsatu-
rated fatty acids. In addition, reduced de novo
synthesis of phospholipids with an associated increase
in the formation of cholesterol in senescent cells was
also observed and exogenous fatty acids were shown
to be preferentially incorporated into the triacylglyc-
erol pool of senescent cells.
In another study, the metabolic alterations associ-
ated with oncogene-induced senescence (OIS), using
Ras-induced senescent human fibroblasts as a model
were investigated (Quijano et al. 2012). Through the
profiling of *300 different intracellular metabolites,
these authors showed that cells that have undergone
OIS develop a metabolic signature which is distinct
from cells which have undergone replicative senes-
cence in response to extended in vitro cell culture. In
the latter, a switch towards glycolysis has been
observed that precedes the onset of senescence (Bittles
and Harper 1984). In OIS, an increase in certain
intracellular long chain fatty acids, including
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eicosanoate, dihomo-linoleate, mead acid and docosa-
dienoate were observed. This altered metabolome was
shown to associate with a decline in lipid synthesis and
increases in fatty acid oxidation. Interestingly, the pro-
inflammatory activity of the senescent secretome was
reduced by inhibition of carnitine palmitoyltransferase
1, the rate limiting step in mitochondrial fatty acid
oxidation, suggesting that alterations in lipid metabo-
lism during OIS may play a role in regulating the pro-
inflammatory senescent secretome. Although the
mechanism underlying the increase in fatty acid levels
during OIS were not fully explored, it may be due to
promyelocytic leukemia (PML) activation of the fatty
acid oxidation pathway through PPAR signalling
(Aird and Zhang 2014). The differences between
replicative senescence and OIS are intriguing; they
may relate to the physiological need in preventing
cancer to switch away from glycolysis as a rapid
source of energy that is harnessed by cancer cells to
enable them to proliferate rapidly versus the increas-
ing insulin resistance that is seen in ageing and which
associates with impaired oxidative metabolism (Bur-
kart et al. 2016). However, while this and other studies
have indicated an increase in glucose uptake during
OIS, a number of other studies have observed either no
change or a significant decrease in glucose
Fig. 1 Schematic
demonstrating the possible
link between cellular
senescence, altered lipid
metabolism and organismal
ageing
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uptake. This may relate to the timing of senescence
induction, the cell type or the oncogene responsible.
A further study compared global lipid profiles and
associated mRNA levels of proliferating and replica-
tive senescent BJ fibroblasts; 19 specific polyunsatu-
rated triacylglycerol species were identified as
undergoing significant changes in lipid composition
during cell senescence (Lizardo et al. 2017). In
addition, significant changes in the expression of
genes involved in specific lipid-related pathways,
including glycerolipid metabolism, glycerophospho-
lipid metabolism, unsaturated fatty acid synthesis and
sphingolipid metabolism were observed during cell
senescence. Based on these lipidomic and transcrip-
tomic analysis, the authors postulated that activation
of CD36-mediated fatty acid uptake and alteration to
glycerolipid biosynthesis may contribute to the accu-
mulation of triacylglycerols during cell senescence. It
was suggested that these changes may be a mechanism
to prevent lipotoxicity during elevated oxidative stress
conditions during cell senescence.
In addition to an altered lipidome during cellular
senescence, elevated ROS, likely from uncoupled
mitochondria, can promote lipid peroxidation which
potentiates cellular damage at distant sites. For
example, stable aldehydes can diffuse from their site
of generation and form adducts at distant locations,
thereby propagating the responses and injury initiated
by ROS (Ramana et al. 2013), including the induction
of cell senescence in neighbouring cells. Flor and Kron
observed an accumulation of lipid-derived aldehydes
such as 4-hydroxy-2-nonenal (4-HNE) during accel-
erated senescence (Flor and Kron 2016). Whereas, the
treatment of cells with either 4-HNE or low (5 Gy) c-
irradiation only generated low levels of cell senes-
cence, combining both 4-HNE and 5 Gy c-irradiation
significantly elevated the senescence response. Fur-
thermore, the use of the aldehyde-sequestering drug
hydralazine blocked cell senescence induction by
25 Gy and etoposide treatment, demonstrating the
potential importance of lipid peroxidation during
therapy-induced senescence (Flor et al. 2016). Despite
the highly damaging and pro-ageing potential of
senescence-derived lipid peroxidation, little research
has been conducted in this area and this requires
further study.
Research on cell senescence has primarily been
undertaken on fibroblasts and more research is
required to explore whether the same phenomena are
observed in cell-types linked to age-related disease
such as in senescent adipocytes, pancreatic beta cells,
renal proximal tubular epithelial cells and vascular
endothelial cells. Whilst different types of senescent
cells may share similarities in lipid metabolism, there
may also be differences that are cell type-dependent or
due to the mechanism of senescence induction and
these require further study to better assess the role of
altered lipid metabolism during ageing and disease.
Finally, an important question to contemplate is
whether the alterations in ROS, lipid metabolism and
mitochondrial lipids observed during ageing and
diseases are due solely to the presence of senescent
cells or whether lipidomic changes can occur in
absence of senescent cell accumulation.
Therapeutic opportunities
Agents that are capable of improving mitochondrial
bioenergetics, enhancing glucose metabolism and
reducing oxidative stress can promote healthy span
(Zhang et al. 2016). Exercise has been found to
stimulate mitochondrial biogenesis and activate the
phase II antioxidant defence system and improved
mitochondrial function is implicated in preventing
age-related diseases (Sun et al. 2014). A class of
mitochondria-located natural antioxidants are the
carotenoids. AD patients exhibit significantly lower
serum concentrations of carotenoids such as lutein,
lycopene and zeaxanthin associated with increased
lipid peroxidation products (Nolan et al. 2014). The
enzymes responsible for metabolizing carotenoids are
partitioned in the mitochondrial membranes and
chronic lycopene administration significantly restores
the mitochondrial respiratory enzyme activities in b-
A1-42 treated rats (Horvath and Daum 2013). Prakash
and Kumar studied the neuroprotective effect of
lycopene against the b-amyloid induced cognitive
impairment and mitochondria oxidative damage in
rats. b-A1-42 treated animals showed poor memory
retention and marked oxidative stress was indicated by
significant increase in oxidative mitochondrial dam-
age, IL-6, TNF-a, and caspase-3 activity. However,
the administration of lycopene improved memory
retention, attenuatedmitochondrial-oxidative damage,
reduced neuro-inflammation and restored brain-
derived neurotrophic factor levels in b-A1-42 treated
rats. The study also indicated that lycopene protected
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against b-A1-42 induced cognitive dysfunction and
modulated amyloidogenesis (Prakash and Kumar
2014). Interventions using targeted carotenoids has
the potential to rescue brain mitochondrial lipids,
metabolism, redox state and energy stability, thereby
increasing lifespan and delaying the appearance of
disease (Kelly et al. 2015), but supplementation with
these nutrients may only support and protect cognitive
health if achieved early enough (Nolan et al. 2015).
Finally, more generally, inhibiting enzyme-catal-
ysed lipid oxidation has also proven beneficial because
of the role that oxidised arachidonic acid products, the
eicosanoids, play in inflammation that underpins
ageing. Non-steroidal anti- inflammatory drugs
(NSAIDs), that include acetic acid, salicylate, propi-
onic acid, fenamate, oxicam, and the COX-2 inhibitor
classes, have analgesic, antipyretic, and anti-inflam-
matory properties. They are reported to have a
beneficial effect on some neurodegenerative diseases
(Rubio-Perez and Morillas-Ruiz 2012).
Mitochondria-specific antioxidants as a potential
therapy in ROS-related diseases
There is a need to explore the potential of mitochon-
dria-specific antioxidants as novel therapeutic strate-
gies targeted towards the prevention, delay or
treatment of mitochondria dysfunction in diseases
related to mitochondria dysfunction (Mdaki et al.
2016).
An imbalance in the activity of ETC complexes I, II
and III leads to ROS generation in both the mitochon-
drial matrix and cytosol, resulting in glutathione
depletion and increased lipid peroxidation. A mito-
chondrion-targeted antioxidant peptide, SS31, has
been reported to protect against oxidative damage
(Ma et al. 2015). The antioxidant peptide has the
ability to confer protective effects against mutant
mitochondria and synaptic toxicities (Hemachandra
Reddy et al. 2017). Hao et al. also reported that SS31
can reduce age-related activation of NFjB in mice
(Hao et al. 2016). Hemachandra et al. observed SS31
was able to cross the blood brain barrier and reached
the mitochondria. SS31 was found to enhance mito-
chondrial biogenesis and synaptic activity by reducing
Ab production, reducing mitochondrial dysfunction
and maintaining mitochondrial dynamics in AD
mouse models (Reddy et al. 2017).
Mitochondria-permeable antioxidants such as edar-
avone, idebenone, a-lipoic acid, carotenoids, vitamin
E, and coenzyme Q10, and mitochondria-targeted
antioxidants such as MitoQ, SkQ and astaxanthin (a
ketocarotenoid from the xanthophyll family) are of
increasing interest (Zhang et al. 2016). Balietti et al.
reported astaxanthin as having a gender-related effect
on ageing rat brain by exerting anti-inflammatory
effects differentially in male and female brains
(Balietti et al. 2016). Idebenone, MitoQ and SkQ have
been specifically explored for the treatment of AD
(Zhang et al. 2016; Selfridge et al. 2013). Idebenone
(2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-
benzoquinonenoben), a short chain benzoquinone is
structurally similar to coenzyme Q10 and functions
both as an antioxidant and electron carrier, however,
its clinical application has been limited to date because
of gastrointestinal, neurotoxic or cardiotoxic side
effects (Zhang et al. 2016). MitoQ a lipophilic
molecule bearing a cation moiety, passes directly
through the mitochondrial membrane where it accu-
mulates and is recognised as an effective mitochon-
dria-targeted antioxidant (Zhang et al. 2016). Another
mitochondria targeted antioxidant is cationic SkQ
[10-(60-plastoquinonyl)decyltriphenyl-phosphonium)]
which also accumulates in the mitochondria. Several
studies have shown that SkQ protects cells from age
related diseases. However, its safety and clinical
usefulness need further investigations. Neither MitoQ
nor SkQ are FDA-approved (Zhang et al. 2016).
Targeting senescent cells
If senescent cells contribute to the generation of lipid
peroxidation products as a consequence of altered
metabolic processes, then therapeutically targeting
senescent cells to reverse such metabolic abnormali-
ties may be a viable approach for reducing their impact
during ageing. No doubt many of the strategies
outlined above would also be pertinent for targeting
senescent cells. For example, strategies which target
fatty acid oxidation might reduce their harmful impact
on localised tissue. Pharmacological inhibition (Eto-
moxir) of carnitine palmitoyltransferase 1, the rate
limiting step in mitochondrial fatty acid oxidation was
shown to normalise metabolic activity, as determined
by oxygen consumption in OIS fibroblasts (Quijano
et al. 2012).
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Alternatively, if indeed senescent cells are a major
source of lipid peroxidation products that promote
ageing, then one strategy may be to remove senescent
cells from tissues altogether. In fact, drugs have
emerged that could potentially eliminate senescent
cells to improve health (see Table 2) [reviewed in (de
Keizer 2017; Soto-Gamez and Demaria 2017; Schmitt
2017)]. More recently, a FOXO4 peptide was shown to
specifically induce apoptosis in senescent cells and
reverse some aspects of ageing (Baar et al. 2017).
Nanoparticles loaded with drugs targeted towards
senescent cells have also been developed (Agostini
et al. 2012; Thapa et al. 2017).
Finally, rather than waiting until senescent cells are
present and then tackling the problems they cause, it
would be better to prevent/reduce their appearance
through life-style changes. For example, it has been
demonstrated in mice that exercise can prevent diet-
induced cell senescence and short-term dietary restric-
tion has been shown to reduce the number of senescent
cells in tissue of mice (Schafer et al. 2016; Wang et al.
2010). It was also suggested that dietary restriction
improves mitochondrial function in tissues through
reduction in cell senescence.
Conclusions
Ageing and age-related diseases have been associated
with mitochondrial uncoupling and elevated ROS
formation. Dysfunctional mitochondria predispose to
altered lipid metabolism and increased lipid peroxi-
dation products. Mitochondrial antioxidants that can
restore function and prevent pathological lipid perox-
idation are showing promise in slowing biological
ageing and therefore they may offer benefit for
slowing the progression to age-related diseases such
as neurodegeneration. In parallel, newer drug classes
are providing a different strategy to delay ageing
through removal of senescent cells. Using these drugs
as tools offer an opportunity to increase our under-
standing of whether the alterations in ROS, lipid
metabolism and mitochondrial lipids observed during
ageing and diseases are due to the accumulation of
senescent cells.
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